Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies
Alexander J. Sandweiss, Vicky Brandt, Huda Y. Zoghbi
The Lancet Neurology (2020) Vol. 19, Iss. 8, pp. 689-698
Closed Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
Chen-Chen Jiang, Lishan Lin, Sen Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 127
Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons
Junming Qian, Xiaonan Guan, Bing Xie, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 679
Open Access | Times Cited: 51
Transtorno do Espectro do Autismo
ANDRÉA APARECIDA FRANCISCO VITAL, ALINE HELEN CORRÊA GARCIA, ANA PAULA DOS SANTOS, et al.
(2021)
Open Access | Times Cited: 86
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Shervin Pejhan, Mojgan Rastegar
Biomolecules (2021) Vol. 11, Iss. 1, pp. 75-75
Open Access | Times Cited: 60
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Thomas Leth Jensen, Casper R. Gøtzsche, David P.D. Woldbye
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 59
Epigenetic genes and epilepsy — emerging mechanisms and clinical applications
Karen M. J. van Loo, Gemma L. Carvill, Albert J. Becker, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 9, pp. 530-543
Open Access | Times Cited: 40
Novel treatments in autism spectrum disorder
Danielle Baribeau, Jacob Vorstman, Evdokia Anagnostou
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 2, pp. 101-110
Closed Access | Times Cited: 38
tRNA therapeutics for genetic diseases
Jeff Coller, Zoya Ignatova
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 2, pp. 108-125
Closed Access | Times Cited: 29
Aging activates escape of the silent X chromosome in the female mouse hippocampus
Margaret Gadek, Cayce K. Shaw, Samira Abdulai-Saiku, et al.
Science Advances (2025) Vol. 11, Iss. 10
Open Access | Times Cited: 1
Self-regulating gene therapy ameliorates phenotypes and overcomes gene dosage sensitivity in a mouse model of Rett syndrome
Paul D. Ross, Kamal K.E. Gadalla, Sophie R. Thomson, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 792
Closed Access | Times Cited: 1
Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome
Nathan P. Achilly, Wei Wang, Huda Y. Zoghbi
Nature (2021) Vol. 592, Iss. 7855, pp. 596-600
Open Access | Times Cited: 51
Energy metabolism in childhood neurodevelopmental disorders
Alfonso Oyarzábal, Uliana Musokhranova, Barros LF, et al.
EBioMedicine (2021) Vol. 69, pp. 103474-103474
Open Access | Times Cited: 50
Disruption of MeCP2–TCF20 complex underlies distinct neurodevelopmental disorders
Jian Zhou, Hamdan Hamdan, Hari Krishna Yalamanchili, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 4
Open Access | Times Cited: 32
RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases
Noélle D. Germain, Wendy K. Chung, Patrick D. Sarmiere
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101148-101148
Closed Access | Times Cited: 31
Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here?
Jacqueline Harris, Christine W. Gao, Jacquelyn Britton, et al.
Human Genetics (2023) Vol. 143, Iss. 4, pp. 607-624
Open Access | Times Cited: 22
Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study
Damian May, Kalé Kponee-Shovein, Malena Mahendran, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The Molecular Function of PURA and Its Implications in Neurological Diseases
Lena Molitor, Sabrina Bacher, Sandra Burczyk, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 38
Novel treatments for autism spectrum disorder based on genomics and systems biology
Danielle Baribeau, Evdokia Anagnostou
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107939-107939
Open Access | Times Cited: 34
Pattern decorrelation in the mouse medial prefrontal cortex enables social preference and requires MeCP2
Pan Xu, Yuanlei Yue, Juntao Su, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review
Giorgia Tascini, Giovanni Battista Dell’Isola, Elisabetta Mencaroni, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 25
State‐of‐the‐art therapies for Rett syndrome
Nicolas Panayotis, Yann Ehinger, Marie‐Solenne Félix, et al.
Developmental Medicine & Child Neurology (2022) Vol. 65, Iss. 2, pp. 162-170
Open Access | Times Cited: 24
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Derek Hong, Lilia M. Iakoucheva
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
MECP2-related disorders while gene-based therapies are on the horizon
Katherine Allison, Mirjana Maletić‐Savatić, Davut Pehli̇van
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
MECP2-Related Disorders in Males
Ainhoa Pascual‐Alonso, Antonio Federico Martínez‐Monseny, Clara Xiol, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9610-9610
Open Access | Times Cited: 32
MECP2 and the biology of MECP2 duplication syndrome
Santosh R. D’Mello
Journal of Neurochemistry (2021) Vol. 159, Iss. 1, pp. 29-60
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top